1. Home
  2. Live Updates
  3. Vertex ai

Live Breaking News & Updates on Vertex ai

Stay informed with the latest breaking news from Vertex ai on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vertex ai and stay connected to the pulse of your community

Will The First Army Unit to Get the New XM7 Rifle Modify It?

The Army says the first unit to field its new rifle and machine gun will have them by next March. After getting the rifle, one wonders if they'll use it as designed?

Maryland , United-states , Wisconsin , Russia , China , Russian , Chinese , Micah-rue , Army-times , Army-lieutenant , Army-aberdeen-proving-ground , Airborne-division

Pixie: Meet 'Pixie,' the Gemini-powered AI assistant Google is developing for Pixel phones

Exclusive to the Pixel 9 series, Pixie promises a highly personalised experience by using data from various Google products on users' phones.

Developers-enterprisesin , Google , Personalised-digital-sidekickrecent , Google-assistant , Gemini-nano , Empowering-developers , Gemini-pro , Google-cloud-vertex , Potential-impactas-pixie , Pixie , Vertex

Insider Selling: Vertex, Inc. (NASDAQ:VERX) Insider Sells $1,439,003.55 in Stock

Vertex, Inc. (NASDAQ:VERX – Get Free Report) insider Item Second Irr. Trust Fbo Jac sold 50,227 shares of the company’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $28.65, for a total value of $1,439,003.55. Following the completion of the sale, the insider now directly owns […]

United-states , William-blair , Silvercrest-asset-management-group , Bryn-mawr-capital-management , Goldman-sachs-group , Vertex-inc , Needham-company , Vanguard-group-inc , Cerity-partners , Schonfeld-strategic-advisors , Nasdaq , Fbo-jac

Vertex will pay Editas Medicine and the Broad Institute millions for rights to their CRISPR patent

Vertex will pay millions to rival Editas Medicine and the Broad Institute so that it can sell its breakthrough gene editing treatment for sickle-cell disease.

Cambridge , Cambridgeshire , United-kingdom , California , United-states , Harvard-university , Massachusetts , Berkeley , Feng-zhang , David-altshuler , Emmanuelle-charpentier , Jacob-sherkow

Vertex (NASDAQ:VERX) Stock Price Down 3.6%

Vertex, Inc. (NASDAQ:VERX – Get Free Report) shares dropped 3.6% during trading on Wednesday . The stock traded as low as $27.32 and last traded at $27.72. Approximately 263,005 shares changed hands during trading, a decline of 29% from the average daily volume of 368,045 shares. The stock had previously closed at $28.76. Wall Street […]

United-states , William-blair , Deutsche-bank , Nasdaq , Goldman-sachs-group , Penserra-capital-management , Fbo-jac , Timessquare-capital-management , Sei-investments-co , Vertex-company-profile , Securities-exchange-commission , Comerica-bank

Analysts Set Vertex, Inc. (NASDAQ:VERX) PT at $27.11

Shares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. […]

United-states , Fbo-kyl , Morgan-stanley , Deutsche-bank , Timessquare-capital-management , Penserra-capital-management , Vertex-inc , Goldman-sachs-group , Nasdaq , Comerica-bank , Securities-exchange-commission

Vertex and CRISPR Therapeutics gain FDA approval for CASGEVY - World's first sickle cell treatment using CRISPR gene editing technology

Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patient’s own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.

Ohio , United-states , California , University-of-chicago , Illinois , Saudi-arabia , Washington , Texas , Ohio-state-university , Switzerland , Australia , Dallas

Crispr Gene Editing: FDA Could Approve First Genetic Therapy That Might Cure Sickle Cell

The Food and Drug Administration is expected to approve a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.


United-kingdom , British , Britain , Reshma-kewalramani , Drug-administration-on , Vertex-pharmaceuticals , Drug-administration , Boston-based-vertex-pharmaceuticals , Crispr-therapeutics , President-reshma-kewalramani , First-crispr-gene-editing-therapy , Crispr

Crispr Gene Editing: FDA Approves First Genetic Therapy That Might Cure Sickle Cell

The Food and Drug Administration approved a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.


United-kingdom , British , Britain , Reshma-kewalramani , Drug-administration-on , Vertex-pharmaceuticals , Drug-administration , Boston-based-vertex-pharmaceuticals , Crispr-therapeutics , President-reshma-kewalramani , First-crispr-gene-editing-therapy , Crispr

U.S. FDA approves two gene therapies for sickle cell disease

Sickle cell disease is a painful, inherited blood disorder that can be debilitating and lead to premature death

United-states , Vertex-pharmaceuticals , Drug-administration-on , Log-increate-free , Drug-administration , Crispr , Treatment , Fda , Body , Patient , Vertex